时间依赖的液体积累指数,用于在心力衰竭的败血性休克中阶段特异性风险分层
Qian-Fei Liu1, Liang Ge1, Di Yao1
1Department of Pulmonary and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, 445000, China.
Current medical science
|January 9, 2026
概括
液体积累指数 (FAI) 动态预测心力衰竭败血休克患者的死亡率. 随着时间的推移,降低FAI门意味着从自由的流体管理转向保守的流体管理,以减少风险.
科学领域:
- 关键护理医学 关键护理医学
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 在心力衰竭的败血性休克中,液体管理具有挑战性,平衡复苏需求与液体过载风险.
- 液体积累指数 (FAI) 是这种人群中潜在的动态预后标志物.
研究的目的:
- 调查连续FAI测量的预后价值在ICU入院后72小时内,以指导感染性休克和心力衰竭患者的流体管理.
主要方法:
- 限制立方脊线 (RCS) 分析,以评估FAI和ICU死亡率之间的关系.
- 多变量考克斯比例危险模型用于量化关联.
- 亚组分析和卡普兰-梅尔曲线以评估一致性和生存差异.
主要成果:
- 在FAI水平和ICU死亡率之间发现了显著的非线性关系.
- 随着时间的推移,最佳FAI截止值下降 (0.87在24小时,0.59在48小时,0.56在72小时).
- 在不同时间点上升的FAI水平与ICU死亡率的增加显著相关.
结论:
- FAI是一种动态和独立的预后标志物,用于患有败血性休克和心力衰竭的重症患者.
- 最佳FAI截止值的时间依赖性下降支持在24小时后转向保守的流体管理.
- 这种战略转变可能有助于减轻这一患者群的死亡风险.
关键词:
危急病患者的病情非常严重.流体积累指数 流体积累指数流体管理流体管理心脏衰竭是因为心脏衰竭.ICU 死亡率 ICU 死亡率预后标志物是一个预后标志物.风险分层是指风险的分层.败血症的冲击是一个令人震惊的结果.更多相关视频
相关概念视频
Heart Failure VII: Nursing Interventions
410
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
410
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Heart Failure II: Pathophysiology
704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Heart Failure III: Clinical Manifestations
465
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
465
Heart Failure V: Medical Management
209
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Rheumatic Heart Disease IV: Nursing Management
262
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
262


